NEWS

CCJ Gabriel
NEWS

MEDIPHARM EXPORTS CANNABIS OIL TO US FOR CLINICAL TRIAL

Canadian marijuana producer MediPharm Labs has completed a shipment of cannabis oil containing both THC and CBD to the United States for use in future clinical trials. While shipping cannabis to the US for scientific purposes isn’t entirely unusual, MediPharm said in a news release that this marks the first time in history that a cannabis product has been sourced from a Canadian licensed producer for what is referred to as a “Phase 2” clinical trial in America. The aforementioned press release said that the trial is being funded by the U.S. National Institutes of Health in Bethesda, Maryland, but did not reveal who exactly was conducting the trial. The delivery occurred on July 28 and MediPharm said the export process relied on its Drug Establishment License and product stability data, the United States’ Innovative New Drug Approval, and U.S. Drug Enforcement Administration import approval. MediPharm said steps to meet those requirements were years in the making and involved significant capital investments. “This development is significant as the majority of cannabis operators in the U.S. are operating under state specific regulations that prohibits them from manufacturing for FDA sanctioned research activities and DEA approved shipments under federal narcotic laws,” MediPharm’s news release noted. MediPharm is aiming to be a leader in the development and production of pharmaceutical cannabinoids and claims to have completed a five-day, in-person inspection by the U.S. Food and Drug Administration last November, which was the first of its kind for a cannabis facility in Canada. MediPharm’s shares trade as LABS on the Toronto Stock Exchange, and with more of these types of game changing moves on the horizon, now would be a ripe opportunity to get invested.


Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients, and advanced derivative products. MediPharm Labs develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets. In 2023, MediPharm acquired VIVO Cannabis Inc. which expanded its reach to medical patients in Canada via Canna Farms medical ecommerce platform. This acquisition also included Harvest Medical Clinics in Canada which provides patients with physician consultations for medical cannabis education and prescriptions. MediPharm continues to break down barriers with these upcoming clinical trials happening in America, and hopefully the people who need marijuana the most get the help they need because of it.

Back to blog

New Products

1 of
1 of
1 of
1 of
1 of